Cluster 3 (n = 95) comprised patients with low miR-375 expression and low IRS1 and AKT2 activity, poor glucose control, and the lowest adherence, as well as the most cardiovascular disease and nephropathy. The gene discussed is IRS1; the disease is cardiovascular disorder.